OPCH
Option Care Health, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+38/100
Last price
30.96
▲ 7.59 (32.48%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
28.55
Prev close
23.37
Day high
31.11
Day low
30.97
Volume
65.08M
Market cap
$4.64B
P/E (TTM)
23.48
52W range
18.01 – 36.80
Day trading desk
Gap from prior close
+22.17%
Prior close 23.37
VWAP
31.03
-0.22% from price
Relative volume
39.76×
Unusually busy
Session range
13.78%
27.51 – 31.30
Position in range
91%
Near session high
ATR (14D)
1.16
3.74% of price
Prior day high
23.49
PDH
Prior day low
22.45
PDL
Bid / ask spread
—
Quote not published
Session volume
126.61M
Avg 3.18M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+35.91%
+34.0%
1M
+28.05%
+26.9%
3M
+44.39%
+39.9%
6M
+11.75%
-6.4%
YTD
-2.70%
-16.9%
1Y
+12.73%
-3.7%
3Y
-4.17%
-86.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on OPCH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.92M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 6, 26 | BHATIA PRATEEK Officer |
STOCK | 39.80K | $0 | Direct |
| May 20, 26 | SULLIVAN TIMOTHY P Director |
STOCK | 13.83K | $107.50K | Direct |
| May 20, 26 | BRANDT ERIC K Director |
STOCK | 11.64K | $58.75K | Direct |
| May 20, 26 | KRAEMER HARRY M. JANSEN JR. Director |
STOCK | 21.08K | $268.52K | Direct |
| May 20, 26 | BIERBOWER ELIZABETH D Director |
STOCK | 9.00K | $0 | Direct |
| May 20, 26 | PATE R CARTER Director |
STOCK | 9.00K | $0 | Direct |
| May 20, 26 | BODEM BARBARA W Director |
STOCK | 9.00K | $0 | Direct |
| May 20, 26 | DECKMANN NATASHA Director |
STOCK | 9.84K | $18.76K | Direct |
| May 20, 26 | WRIGHT NORMAN L Director |
STOCK | 9.00K | $0 | Direct |
| May 19, 26 | SMYSER COLLIN General Counsel |
— | 812 | — | Direct |
| May 7, 26 | SULLIVAN TIMOTHY P Director |
BUY | 24.15K | $499.67K | Direct |
| May 4, 26 | KRAEMER HARRY M. JANSEN JR. Director |
BUY | 36.61K | $783.77K | Direct |
| May 4, 26 | RADEMACHER JOHN CHARLES Chief Executive Officer |
BUY | 12.50K | $264.71K | Direct |
| May 4, 26 | SETHNA MEENAL Chief Financial Officer |
BUY | 16.23K | $327.07K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BHATIA PRATEEK |
Officer | 39.80K | Stock Award(Grant) |
GOLDING DAVID W |
Director | 116.53K | Purchase |
GRASHOFF CHRISTOPHER L |
Officer | 48.56K | Stock Award(Grant) |
KRAEMER HARRY M. JANSEN JR. |
Director | 471.08K | Stock Award(Grant) |
RADEMACHER JOHN CHARLES |
Chief Executive Officer | 695.15K | Purchase |
SETHNA MEENAL |
Chief Financial Officer | 98.34K | Purchase |
SHAPIRO MICHAEL H |
Chief Financial Officer | 311.93K | Stock Award(Grant) |
SMYSER COLLIN |
General Counsel | 77.51K | Conversion of Exercise of derivative security |
SULLIVAN TIMOTHY P |
Director | 87.22K | Stock Award(Grant) |
WHITWORTH LUKE |
Chief Operating Officer | 202.24K | Stock Award(Grant) |
Fundamentals
Market cap$4.64B
Enterprise value$5.71B
Revenue (TTM)$5.69B
Gross profit$1.09B
EBITDA$405.09M
Net income$209.58M
EPS (TTM)$1.32
Free cash flow$256.07M
Total cash$196.78M
Total debt$1.27B
Book value / share$8.41
Shares outstanding149.79M
Float147.71M
Short % of float11.26%
Dividend yield0.00%
Beta (5Y)0.58
Valuation & profitability ratios
Trailing P/E23.48
Forward P/E14.88
PEG ratio1.13
Price / sales—
Price / book3.69
EV / revenue1.00
EV / EBITDA14.11
Gross margin19.06%
Operating margin5.90%
Profit margin3.68%
Return on equity16.00%
Return on assets6.17%
Debt / equity100.65
Current ratio1.47
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.65B | $5.00B | $4.30B | $3.94B | +13.0% |
| Operating revenue | $5.65B | $5.00B | $4.30B | $3.94B | +13.0% |
| Cost of revenue | $4.56B | $3.99B | $3.32B | $3.08B | +14.5% |
| Gross profit | $1.09B | $1.01B | $981.22M | $866.92M | +7.4% |
| Selling, general & admin | $682.45M | $630.25M | $607.43M | $566.12M | +8.3% |
| Total operating expense | $749.99M | $691.16M | $666.63M | $626.69M | +8.5% |
| Operating income | $337.91M | $321.83M | $314.60M | $240.23M | +5.0% |
| Net interest income | -$54.56M | -$49.03M | -$51.25M | -$53.81M | -11.3% |
| Pre-tax income | $282.90M | $283.60M | $358.74M | $205.77M | -0.2% |
| Tax provision | $75.31M | $71.78M | $91.65M | $55.21M | +4.9% |
| Net income | $207.59M | $211.82M | $267.09M | $150.56M | -2.0% |
| Net income to common | $207.59M | $211.82M | $267.09M | $150.56M | -2.0% |
| Basic EPS | 1.28 | 1.23 | 1.49 | 0.83 | +4.1% |
| Diluted EPS | 1.27 | 1.23 | 1.48 | 0.83 | +3.3% |
| EBIT | $337.46M | $332.63M | $409.99M | $259.57M | +1.5% |
| EBITDA | $408.15M | $396.13M | $472.19M | $325.01M | +3.0% |
| Basic shares | 162.10M | 171.57M | 178.97M | 181.10M | -5.5% |
| Diluted shares | 163.37M | 172.84M | 180.38M | 182.07M | -5.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $232.62M | $412.56M | $343.85M | $294.19M | -43.6% |
| Cash & short-term investments | $232.62M | $412.56M | $343.85M | $294.19M | -43.6% |
| Accounts receivable | $473.57M | $409.73M | $377.66M | $377.54M | +15.6% |
| Inventory | $471.15M | $388.13M | $274.00M | $224.28M | +21.4% |
| Total current assets | $1.26B | $1.32B | $1.09B | $994.34M | -4.4% |
| Property, plant & equipment | $230.49M | $213.90M | $204.79M | $180.75M | +7.8% |
| Goodwill & intangibles | $1.92B | $1.84B | $1.88B | $1.90B | +4.1% |
| Total assets | $3.46B | $3.42B | $3.22B | $3.11B | +1.0% |
| Total current liabilities | $829.35M | $780.15M | $618.31M | $565.35M | +6.3% |
| Current debt | $6.78M | $6.51M | $6.00M | $6.00M | +4.1% |
| Long-term debt | $1.15B | $1.10B | $1.06B | $1.06B | +4.5% |
| Total debt | $1.27B | $1.22B | $1.17B | $1.16B | +4.5% |
| Total liabilities | $2.13B | $2.02B | $1.80B | $1.73B | +5.5% |
| Retained earnings | $876.92M | $669.34M | $457.51M | $190.42M | +31.0% |
| Shareholder equity | $1.33B | $1.40B | $1.42B | $1.39B | -5.5% |
| Working capital | $435.62M | $542.48M | $475.95M | $428.99M | -19.7% |
| Net tangible assets | -$589.53M | -$437.02M | -$453.97M | -$511.44M | -34.9% |
| Shares issued | 184.52M | 183.85M | 182.91M | 182.34M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $207.59M | $211.82M | $267.09M | $150.56M | -2.0% |
| Depreciation & amortisation | $70.69M | $63.50M | $62.20M | $65.43M | +11.3% |
| Stock-based compensation | $39.96M | $36.14M | $30.48M | $16.78M | +10.5% |
| Change in working capital | -$99.75M | -$20.25M | -$21.45M | -$29.78M | -392.7% |
| Operating cash flow | $258.45M | $323.39M | $371.30M | $267.55M | -20.1% |
| Capital expenditure | -$41.31M | -$35.61M | -$41.87M | -$35.36M | -16.0% |
| Investing cash flow | -$161.08M | -$36.47M | -$56.51M | -$108.05M | -341.7% |
| Share buybacks | -$309.95M | -$252.73M | -$250.26M | $0 | -22.6% |
| Financing cash flow | -$277.31M | -$218.21M | -$265.13M | $15.27M | -27.1% |
| Free cash flow | $217.14M | $287.79M | $329.43M | $232.19M | -24.5% |
| End cash position | $232.62M | $412.56M | $343.85M | $294.19M | -43.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.44B | $1.35B | $1.47B | $1.44B | $1.42B | +6.8% |
| Operating revenue | $1.44B | $1.35B | $1.47B | $1.44B | $1.42B | +6.8% |
| Cost of revenue | $1.18B | $1.09B | $1.18B | $1.16B | $1.15B | +7.9% |
| Gross profit | $267.25M | $262.01M | $282.90M | $272.90M | $269.04M | +2.0% |
| Selling, general & admin | $164.66M | $174.56M | $172.14M | $172.10M | $170.09M | -5.7% |
| Total operating expense | $182.11M | $189.47M | $191.40M | $188.40M | $186.33M | -3.9% |
| Operating income | $85.14M | $72.55M | $91.50M | $84.51M | $82.71M | +17.4% |
| Net interest income | -$14.02M | -$13.30M | -$12.73M | -$14.15M | -$14.45M | -5.4% |
| Pre-tax income | $73.99M | $61.00M | $81.52M | $68.97M | $68.86M | +21.3% |
| Tax provision | $20.07M | $15.66M | $23.01M | $17.15M | $18.34M | +28.2% |
| Net income | $53.91M | $45.34M | $58.50M | $51.82M | $50.52M | +18.9% |
| Net income to common | $53.91M | $45.34M | $58.50M | $51.82M | $50.52M | +18.9% |
| Basic EPS | 0.35 | 0.29 | 0.37 | 0.32 | 0.31 | +20.7% |
| Diluted EPS | 0.35 | 0.29 | 0.37 | 0.32 | 0.31 | +20.7% |
| EBIT | $88.01M | $74.31M | $94.25M | $83.11M | $83.31M | +18.4% |
| EBITDA | $106.39M | $89.96M | $114.57M | $100.16M | $100.26M | +18.3% |
| Basic shares | 152.93M | 156.65M | 158.26M | 161.83M | 162.93M | -2.4% |
| Diluted shares | 153.49M | 158.21M | 159.83M | 163.09M | 164.13M | -3.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $193.77M | $177.32M | $232.62M | $309.82M | $198.82M | +9.3% |
| Cash & short-term investments | $193.77M | $177.32M | $232.62M | $309.82M | $198.82M | +9.3% |
| Accounts receivable | $356.61M | $516.44M | $473.57M | $474.50M | $481.25M | -30.9% |
| Inventory | $399.61M | $415.69M | $471.15M | $415.72M | $403.54M | -3.9% |
| Total current assets | $1.20B | $1.20B | $1.26B | $1.28B | $1.18B | +0.5% |
| Property, plant & equipment | $229.76M | $229.71M | $230.49M | $226.74M | $229.81M | +0.0% |
| Goodwill & intangibles | $1.90B | $1.91B | $1.92B | $1.93B | $1.93B | -0.5% |
| Total assets | $3.38B | $3.38B | $3.46B | $3.48B | $3.38B | -0.0% |
| Total current liabilities | $819.48M | $729.75M | $829.35M | $823.91M | $773.62M | +12.3% |
| Current debt | $6.78M | $6.78M | $6.78M | $6.78M | $6.51M | 0.0% |
| Long-term debt | $1.15B | $1.15B | $1.15B | $1.16B | $1.10B | -0.1% |
| Total debt | $1.27B | $1.27B | $1.27B | $1.28B | $1.23B | -0.2% |
| Total liabilities | $2.12B | $2.03B | $2.13B | $2.12B | $2.02B | +4.4% |
| Retained earnings | $976.18M | $922.26M | $876.92M | $818.42M | $766.60M | +5.8% |
| Shareholder equity | $1.26B | $1.35B | $1.33B | $1.36B | $1.36B | -6.7% |
| Working capital | $381.12M | $465.36M | $435.62M | $458.86M | $401.61M | -18.1% |
| Net tangible assets | -$637.48M | -$555.58M | -$589.53M | -$566.43M | -$573.62M | -14.7% |
| Shares issued | 149.78M | 185.18M | 184.52M | 184.50M | 184.48M | -19.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $53.91M | $45.34M | $58.50M | $51.82M | $50.52M | +18.9% |
| Depreciation & amortisation | $18.38M | $15.65M | $20.32M | $17.05M | $16.95M | +17.4% |
| Stock-based compensation | $8.38M | $10.20M | $9.32M | $11.13M | $10.71M | -17.8% |
| Change in working capital | $96.39M | -$89.73M | -$65.45M | $49.03M | $4.64M | +207.4% |
| Operating cash flow | $183.59M | -$12.11M | $35.89M | $139.44M | $90.33M | +1,616.1% |
| Capital expenditure | -$11.08M | -$9.05M | -$13.65M | -$9.20M | -$9.10M | -22.5% |
| Investing cash flow | -$11.68M | -$9.32M | -$13.65M | -$11.72M | -$9.02M | -25.3% |
| Share buybacks | -$153.01M | -$17.54M | -$95.06M | -$62.46M | -$52.21M | -772.4% |
| Financing cash flow | -$155.47M | -$33.87M | -$99.44M | -$16.71M | -$53.87M | -359.0% |
| Free cash flow | $172.52M | -$21.16M | $22.25M | $130.24M | $81.24M | +915.5% |
| End cash position | $193.77M | $177.32M | $232.62M | $309.82M | $198.82M | +9.3% |
Options analytics
Put / call volume
1.66
Put-heavy session
Put / call open interest
0.10
Positioning, not flow
Max pain
20.00
-35.5% from spot
ATM implied vol
28.0%
Nearest strike to spot
Skew (10% OTM)
+0.4%
Puts bid over calls
Call volume
835
Contracts, this expiry
Put volume
1.39K
Contracts, this expiry
Heaviest call OI
35.00
5.03K contracts
Heaviest put OI
22.50
367 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.43 | 0.45 | +5.4% |
| Mar 2026 | 0.37 | 0.40 | +8.1% |
| Dec 2025 | 0.47 | 0.46 | -1.8% |
| Sep 2025 | 0.43 | 0.45 | +4.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.49 | 11 | $1.48B | +2.9% |
| Next quarter | 0.54 | 10 | $1.49B | +1.6% |
| Current year | 1.88 | 11 | $5.76B | +1.9% |
| Next year | 2.08 | 11 | $6.13B | +6.4% |
Analyst targets & ownership
Mean target$30.21
High target$39.00
Low target$23.00
Implied upside-2.44%
Analyst count10
ConsensusNONE
Strong buy / Buy4 / 4
Hold3
Sell / Strong sell0 / 0
Held by insiders1.28%
Held by institutions108.83%
Institutions holding509
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
23.71
+30.56% from price
SMA 20
23.83
+30.11% from price
SMA 50
23.75
+30.55% from price
SMA 100
22.50
+37.62% from price
SMA 200
26.44
+17.24% from price
EMA 12
24.34
+27.20% from price
EMA 26
23.91
+29.49% from price
EMA 50
23.61
+31.13% from price
RSI (14)
83.7
Overbought
MACD (12,26,9)
0.43
Hist 0.43
ATR (14)
1.16
3.73% of price
Realised vol 30D
84.1%
Annualised
Bollinger upper
27.33
20, 2σ
Bollinger lower
20.32
20, 2σ
50 / 200 cross
Death
23.75 vs 26.44
Trend bias
Above 200
+17.24%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.09
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
84.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-46.7%
Peak to trough
Max drawdown 5Y
-46.7%
Peak to trough
ATR 14
1.16
3.73% of price
Beta (reported)
0.58
5Y monthly, from filing
Short interest
Shares short
12.10M
Prior 12.04M
Change vs prior
+0.5%
Shorts adding
% of float
11.26%
Elevated
% of shares out
8.08%
Against total outstanding
Days to cover
7.1
Crowded exit
Float
147.71M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 30, 26 | Deutsche Bank | DOWNGRADE | Buy | Hold |
| Jul 17, 26 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Jun 8, 26 | Goldman Sachs | INITIATED | Neutral | Neutral |
| May 6, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| May 4, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 1, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| May 1, 26 | UBS | MAINTAINED | Buy | Buy |
| May 1, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Jan 16, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jan 13, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jan 13, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Dec 11, 25 | Stephens & Co. | INITIATED | — | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateFeb 3, 2020
Last split1:4
Split dateFeb 3, 2020
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-10-06
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-05-22
Corporate Changes & Voting Matters
8-K · 2026-05-12
Corporate Changes & Voting Matters
8-K · 2026-05-05
Periodic Financial Reports
10-Q · 2026-04-30
Proxy Statements
DEFA14A · 2026-04-08
Corporate Changes & Voting Matters
8-K · 2026-04-02
Headlines
Stocks to Watch Recap: SpaceX, Nvidia, Lamb Weston, Uber
The Wall Street Journal · 6h ago
Option Health Care Skyrockets On $5.8 Billion McKesson, CD&R Takeover
Investor's Business Daily · 7h ago
Why Option Care Health (OPCH) Stock Is Trading Up Today
StockStory · 8h ago
Sector Update: Healthcare Stocks Mixed Late Afternoon
MT Newswires · 8h ago
Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid
Insider Monkey · 8h ago
Why Option Care Health Stock Skyrocketed on Tuesday
Motley Fool · 9h ago
Sector Update: Healthcare Stocks Mixed Tuesday Afternoon
MT Newswires · 10h ago
McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal
MT Newswires · 10h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.